colchicine has been researched along with Alloxan Diabetes in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (25.00) | 18.7374 |
1990's | 3 (18.75) | 18.2507 |
2000's | 9 (56.25) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brighente, IM; Cazarolli, LH; Folador, P; Moresco, HH; Pizzolatti, MG; Silva, FR | 1 |
Han, DS; Han, SH; Jin, R; Jung, DS; Kang, SW; Kim, DK; Kim, SH; Kwak, SJ; Lee, JE; Lee, SH; Li, JJ; Moon, SJ; Ryu, DR; Yoo, TH | 1 |
CUTTING, WC; LAQUEUR, GL | 1 |
Calaghan, SC; Howarth, FC; Qureshi, MA; White, E | 1 |
Bucci, TJ; Mehendale, HM; Shankar, K; Vaidya, VS; Wang, T | 1 |
Apte, UM; Bucci, TJ; Manautou, JE; Mehendale, HM; Ronis, MJ; Shankar, K; Vaidya, VS | 1 |
Bucci, TJ; Corton, JC; Liu, J; Mehendale, HM; Shankar, K; Vaidya, VS; Waalkes, MP | 1 |
Dnyanmote, AV; Latendresse, JR; Lock, EA; Mehendale, HM; Sawant, SP; Warbritton, AA | 2 |
Nassar, CF; Nasser, MG; Shayban, ES | 1 |
Dibu, RG; Nassar, CF | 1 |
Ewart, HS; Severson, D; Shimoni, Y | 1 |
Rattner, JB; Shimoni, Y | 1 |
Fernstrom, JD; Kwok, RP; Liu, B | 1 |
Glass, P; Müller, H; Schmidt, R; Schneider, S; Unger, E | 1 |
Bikhazi, AB; Ghaleb, TA; Saad, SH | 1 |
16 other study(ies) available for colchicine and Alloxan Diabetes
Article | Year |
---|---|
Mechanism of action of the stimulatory effect of apigenin-6-C-(2''-O-alpha-l-rhamnopyranosyl)-beta-L-fucopyranoside on 14C-glucose uptake.
Topics: Alloxan; Androstadienes; Animals; Biological Transport; Blood Glucose; Carbon Radioisotopes; Colchicine; Cycloheximide; Diabetes Mellitus, Experimental; Disaccharides; Disease Models, Animal; Dose-Response Relationship, Drug; Flavones; Flavonoids; Glucose; Hyperglycemia; Indoles; Insulin; Insulin Secretion; Magnoliopsida; Male; Muscle, Skeletal; Plant Leaves; Rats; Rats, Wistar; Tissue Distribution; Wortmannin | 2009 |
Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy.
Topics: Animals; Cell Movement; Cells, Cultured; Chemokine CCL2; Colchicine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Extracellular Matrix; Fibronectins; Inflammation; Intercellular Adhesion Molecule-1; Macrophages; Rats; RNA, Messenger; Streptozocin; Tubulin Modulators | 2009 |
Alloxan diabetes cellular changes, and inhibitory actions of colchicine.
Topics: Animals; Colchicine; Diabetes Mellitus; Diabetes Mellitus, Experimental; Humans | 1946 |
Cardiac microtubules are more resistant to chemical depolymerisation in streptozotocin-induced diabetes in the rat.
Topics: Animals; Cardiomyopathies; Colchicine; Diabetes Mellitus, Experimental; Male; Microtubules; Myocardium; Myocytes, Cardiac; Polymers; Rats; Rats, Wistar | 2002 |
Streptozotocin-induced diabetic mice are resistant to lethal effects of thioacetamide hepatotoxicity.
Topics: Animals; Antineoplastic Agents; Blood Glucose; Carcinogens; Chemical and Drug Induced Liver Injury; Colchicine; Diabetes Mellitus, Experimental; DNA; Enzymes; Immunohistochemistry; Liver Glycogen; Male; Mice; Mice, Inbred C57BL; Proliferating Cell Nuclear Antigen; Thioacetamide | 2003 |
Type 1 diabetic mice are protected from acetaminophen hepatotoxicity.
Topics: Acetaminophen; Alanine Transaminase; Analgesics, Non-Narcotic; Animals; Aspartate Aminotransferases; Bromobenzenes; Carbon Tetrachloride; Cell Division; Chemical and Drug Induced Liver Injury; Colchicine; Diabetes Mellitus, Experimental; Disease Models, Animal; DNA; Drug Therapy, Combination; Liver; Liver Regeneration; Male; Mice; Microsomes, Liver; Proliferating Cell Nuclear Antigen | 2003 |
Activation of PPAR-alpha in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity.
Topics: Acetaminophen; Animals; Cell Division; Chemical and Drug Induced Liver Injury; Colchicine; Cytochrome P-450 Enzyme System; Cytoprotection; Diabetes Mellitus, Experimental; Gene Expression Profiling; Liver; Liver Diseases; Mice; Mice, Knockout; Models, Biological; NF-kappa B; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2003 |
Diabetic mice are protected from normally lethal nephrotoxicity of S-1,2-dichlorovinyl-L-cysteine (DCVC): role of nephrogenic tissue repair.
Topics: Animals; Area Under Curve; Blood Urea Nitrogen; Bromodeoxyuridine; Cell Nucleus; Colchicine; Creatinine; Cysteine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Half-Life; Immunohistochemistry; Injections, Intraperitoneal; Kidney Tubules, Proximal; Lyases; Male; Mice; Proliferating Cell Nuclear Antigen; Regeneration; S Phase; Streptozocin; Thymidine; Tritium | 2006 |
Calpastatin overexpression prevents progression of S-1,2-dichlorovinyl-l-cysteine (DCVC)-initiated acute renal injury and renal failure (ARF) in diabetes.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antimitotic Agents; Calcium-Binding Proteins; Calpain; Colchicine; Cysteine Proteinase Inhibitors; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Kidney Function Tests; Kidney Tubules, Proximal; Longevity; Male; Mice; Regeneration | 2006 |
Calcium binding to normal, regenerating and diabetic liver plasma membrane.
Topics: Animals; Binding Sites; Calcium; Cell Membrane; Colchicine; Diabetes Mellitus, Experimental; In Vitro Techniques; Liver; Liver Regeneration; Male; Procaine; Rats; Rats, Inbred Strains | 1984 |
Pyridoxine binding to normal and diabetic liver plasma membrane.
Topics: Animals; Binding Sites; Cell Membrane; Colchicine; Diabetes Mellitus, Experimental; Insulin; Liver; Male; Procaine; Pyridoxine; Rats; Rats, Inbred Strains; Time Factors; Vincristine | 1984 |
Insulin stimulation of rat ventricular K+ currents depends on the integrity of the cytoskeleton.
Topics: Actins; Animals; Blood Glucose; Colchicine; Cytochalasin D; Cytoskeleton; Diabetes Mellitus, Experimental; Hypoglycemic Agents; In Vitro Techniques; Insulin; Membrane Potentials; Myocardium; Nucleic Acid Synthesis Inhibitors; Patch-Clamp Techniques; Phalloidine; Potassium Channels; Rats; Rats, Sprague-Dawley | 1999 |
Type 1 diabetes leads to cytoskeleton changes that are reflected in insulin action on rat cardiac K(+) currents.
Topics: Animals; Colchicine; Cycloheximide; Cytochalasin D; Cytoskeleton; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electric Conductivity; Fluorescent Antibody Technique, Indirect; Heart; Heart Ventricles; Insulin; Myocardium; Nucleic Acid Synthesis Inhibitors; Potassium Channels; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Tubulin | 2001 |
Colchicine-induced increases in immunoreactive neuropeptide levels in hypothalamus: use as an index of biosynthesis.
Topics: Animals; Arginine Vasopressin; Colchicine; Diabetes Mellitus, Experimental; Hypothalamus; Male; Median Eminence; Oxytocin; Rats; Rats, Inbred Strains; Somatostatin; Streptozocin | 1991 |
[Effect of alloxans on pancreatic B-cells with special regard to the alloxan-metal-complex theory. I. Effects of alloxan, alloxan-zinc chelates, dilauric acid and colchicine on blood sugar and rate of mitosis of B-cell Langerhans islets].
Topics: Alloxan; Animals; Barbiturates; Blood Glucose; Chelating Agents; Colchicine; Diabetes Mellitus, Experimental; Islets of Langerhans; Kinetics; Metaphase; Mitosis; Rats; Reference Values; Zinc | 1990 |
Effect of treatment with phospholipase A2, colchicine, and beta-galactosidase on agglutination of rat hepatocytes.
Topics: Agglutination; Animals; beta-Galactosidase; Colchicine; Concanavalin A; Diabetes Mellitus, Experimental; Galactosidases; Liver; Phospholipases; Phospholipases A; Phospholipases A2; Rats; Rats, Inbred Strains; Time Factors | 1989 |